Cargando…
Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells
Platinum-taxane combination chemotherapy still represents the standard of care for advanced non-small cell lung cancer (NSCLC) with no targetable driver mutations. However, the efficacy of these drugs has plateaued at 10–14 months primarily due to dose-limiting toxicity, chemoresistance, and metasta...
Autores principales: | Kyakulaga, Al Hassan, Aqil, Farrukh, Munagala, Radha, Gupta, Ramesh C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185067/ https://www.ncbi.nlm.nih.gov/pubmed/32362998 http://dx.doi.org/10.18632/oncotarget.27519 |
Ejemplares similares
-
Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
por: Kyakulaga, Al Hassan, et al.
Publicado: (2018) -
Promising molecular targeted therapies in breast cancer
por: Munagala, Radha, et al.
Publicado: (2011) -
Chemopreventive
and Therapeutic Activity of Dietary
Blueberry against Estrogen-Mediated Breast Cancer
por: Jeyabalan, Jeyaprakash, et al.
Publicado: (2013) -
Cumin Prevents 17β-Estradiol-Associated Breast Cancer in ACI Rats
por: Aqil, Farrukh, et al.
Publicado: (2021) -
Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices
por: Aqil, Farrukh, et al.
Publicado: (2017)